GAMMA Investing’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4K Sell
603
-1,080
-64% -$18.3K ﹤0.01% 3099
2026
Q1
$26.8K Sell
1,683
-2,913
-63% -$63.2K ﹤0.01% 2563
2025
Q4
$121K Buy
4,596
+41
+0.9% +$1.06K 0.01% 1436
2025
Q3
$103K Buy
4,555
+9
+0.2% +$185 0.01% 1495
2025
Q2
$90.4K Buy
4,546
+144
+3% +$2.81K 0.01% 1527
2025
Q1
$74.4K Buy
4,402
+2,269
+106% +$38.6K 0.01% 1492
2024
Q4
$39.4K Buy
2,133
+667
+45% +$13K ﹤0.01% 1839
2024
Q3
$31.9K Buy
1,466
+301
+26% +$6.73K ﹤0.01% 1811
2024
Q2
$22.9K Buy
1,165
+778
+201% +$16.2K ﹤0.01% 1769
2024
Q1
$8.4K Sell
387
-42
-10% -$1.04K ﹤0.01% 2152
2023
Q4
$10.5K Buy
+429
New +$11.5K ﹤0.01% 1877

Other funds holding FLGT

GAMMA Investing's FLGT Position: Q2 2026 in Review

GAMMA Investing reduced its Fulgent Genetics (FLGT) stake by 64% in Q2 2026, selling an estimated $18.3K and leaving 603 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3099.

GAMMA Investing first reported a position in FLGT in Q4 2023 and has held it in 11 quarters since. The position peaked at $121K in Q4 2025. 19 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • GAMMA Investing held 603 shares of Fulgent Genetics worth $12.4K as of Q2 2026.
  • GAMMA Investing sold 1,080 Fulgent Genetics shares in Q2 2026, an estimated $18.3K.
  • Fulgent Genetics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3099 holding.
  • GAMMA Investing first reported a position in Fulgent Genetics in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Fulgent Genetics position peaked at $121K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.